Alexandra Michaela Bendel

Alexandra Michaela Bendel

Auto-generated profile, based on publicly available information

Alexandra Michaela Bendel

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Genome Biology
Verified
Journal Article
Open access
PDF file
CSCharlotte Soneson
Charlotte Soneson
ABAlexandra M. Bendel
Alexandra M. Bendel
GDGuillaume Diss
Guillaume Diss
MSMichael B. Stadler
Michael B. Stadler
Multiplexed assays of variant effect (MAVE) experimentally measure the effect of large numbers of sequence variants by selective enrichment of sequences with desirable properties followed by quantification by sequencing. mutscan is an R package for flexible analysis of such experiments, covering the entire workflow from raw reads up to statistical analysis and visualization. The core components are implemented in C++ for efficiency. Various experimental designs are supported, including single or paired reads with optional unique molecular identifiers. To find variants with changed relative abundance, mutscan employs established statistical models provided in the edgeR and limma packages. mutscan is available from https://github.com/fmicompbio/mutscan.

13 August 2026 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
PGPius Galli
Pius Galli
SXShuhao Xiao
Shuhao Xiao
YMYanxiang Meng
Yanxiang Meng
AHAlexander Hanzl
Alexander Hanzl
ABAlexandra M. Bendel
Alexandra M. Bendel
NTNicolas H. Thomä
Nicolas H. Thomä
Molecular glue degraders (MGDs), such as pomalidomide, induce degradation of non-native substrates by the cullin-RING E3 ligase 4 (CRL4) through its substrate receptor cereblon (CRBN). Here, to explore CRBN programmability, we tested whether reported CRBN–MGD substrates are part of a network of latent CRBN interactors, proteins capable of MGD-induced CRBN binding without detectable degradation. Leveraging a highly parallel protein complementation assay (GluePCA) to measure MGD-induced interaction between CRBN and zinc fingers, we identified ~210 zinc fingers bound to CRBN–pomalidomide, where top binders are already reported as degraded by dedicated MGDs. To map latent CRBN–MGD interactions proteome-wide and define the accessible CRBN interaction space, we combined artificial intelligence-derived protein surface queries (MaSIF-mimicry) with GluePCA. This pipeline identified 6 known and 43 novel CRBN–pomalidomide binders, including orthogonally validated hits. We find that these binders provide privileged starting points for MGD development. We expect this binding-focused workflow to be applicable to other MGD–E3 ligase systems, potentially extending the scope of this emerging drug class.

20 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAlexandra M. Bendel
Alexandra M. Bendel
AFAndré J. Faure
André J. Faure
DKDominique Klein
Dominique Klein
KSKenji Shimada
Kenji Shimada
GKGeorg Kempf
Georg Kempf
GDGuillaume Diss
Guillaume Diss
Proteins function in crowded cellular environments in which they must bind to specific target proteins but also avoid binding to many other off-target proteins. In large protein families this task is particularly challenging because many off-target proteins have very similar structures. How this specificity of physical protein-protein interactions in cellular networks is encoded and evolves is not very well understood. Here we address the question of specificity-encoding by comprehensively quantifying the effects of all mutations in one protein, JUN, on its binding to all other members of a protein family, the 54 human basic leucine zipper transcription factors. Fitting a global thermodynamic model to the data reveals that most affinity changing mutations equally affect JUN’s propensity to bind to all its interaction partners. Mutations that alter the specificity of binding are much rarer. These specificity-altering mutations are, however, distributed throughout the JUN interaction interface. JUN’s interaction specificity is encoded by both positive determinants that promote on-target interactions and negative determinants that prevent off-target interactions. Indeed, about half of the specificity-defining residues in JUN have dual functions and both promote on-target binding and prevent off-target binding. Whereas nearly all mutations that alter specificity are pleiotropic and also alter the affinity of binding to all interaction partners, the converse is not true with mutations outside of the interface able to tune affinity without affecting specificity. Our results provide the first global view of how mutations in a protein affect binding to all its potential interaction partners and reveal the distributed encoding of specificity and affinity in an interaction interface. They also show how the modular architecture of coiled-coils provides an elegant solution to the challenge of optimising specificity and affinity in a large protein family.

24 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ABAlexandra Michaela Bendel
Alexandra Michaela Bendel
KSKristjana Skendo
Kristjana Skendo
DKDominique Klein
Dominique Klein
KSKenji Schimada
Kenji Schimada
KKKotryna Kauneckaite-Griguole
Kotryna Kauneckaite-Griguole
GDGuillaume Diss
Guillaume Diss
Deep Mutational Scanning (DMS) assays are powerful tools to study sequence-function relationships by measuring the effects of thousands of sequence variants on protein function. During a DMS experiment, several technical artefacts might distort non-linearly the functional score obtained, potentially biasing the interpretation of the results. We therefore tested several technical parameters in the deepPCA workflow, a DMS assay for protein-protein interactions, in order to identify technical sources of non-linearities. We found that parameters common to many DMS assays such as amount of transformed DNA, timepoint of harvest and library composition can cause non-linearities in the data. Designing experiments in a way to minimize these non-linear effects will improve the quantification and interpretation of mutation effects.

21 November 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
LSLaura A. Schneider
Laura A. Schneider
ABAlexandra M. Bendel
Alexandra M. Bendel
RBRegina Baur
Regina Baur
NTNicolas H. Thomä
Nicolas H. Thomä

25 September 2026 in Science Advances
Verified
Journal Article
Open access
SSShihua Shi
Shihua Shi
ABAlexandra Bendel
Alexandra Bendel
GKGeorg Kempf
Georg Kempf
JSJacint Sanchez
Jacint Sanchez
SMSohei Majima
Sohei Majima
LWLonglong Wang
Longlong Wang
While protein ubiquitination has been extensively studied, the roles of unanchored ubiquitin and its chains remain less understood, largely due to a lack of specific, high-affinity tools for their enrichment and visualization. To address this, we used high-throughput affinity maturation and computational protein design to engineer novel proteins that selectively bind unanchored ubiquitin. We first enhanced the binding affinity of the zinc finger domain of histone deacetylase 6, a natural unanchored ubiquitin binder, by including its unstructured amino-terminal loop and introducing the V1091L mutation. Using RFdiffusion, we then designed 11 novel ubiquitin-binding proteins (UBiPs), among which UBiP10 showed specificity for unanchored ubiquitin. This protein enriched unanchored ubiquitin from cells and influenza A virions and served as a probe to determine its cellular levels, supporting a relative decrease upon proteasome inhibition. Imaging studies with UBiP10 further revealed a novel unanchored ubiquitin coat around aggresomes, illustrating the potential of UBiP10 as a unique tool to study unanchored ubiquitin in cellular regulation.